Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 1,306Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3DR REDDYS

02 6AVYXA HOLDINGS

03 3EUGIA PHARMA SPECLTS

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Patent Expiration Date : 2036-02-15

CYCLOPHOSPHAMIDE

US Patent Number : 10993952

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 212501

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2036-02-15

Dr Reddy Company Banner

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Patent Expiration Date : 2036-02-15

CYCLOPHOSPHAMIDE

US Patent Number : 10993952

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 212501

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2036-02-15

Dr Reddy Company Banner

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Patent Expiration Date : 2036-02-15

CYCLOPHOSPHAMIDE

US Patent Number : 10993952

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 212501

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2036-02-15

Dr Reddy Company Banner

04

arrow
euroPLX 86 Munich
Not Confirmed
arrow
euroPLX 86 Munich
Not Confirmed

CYCLOPHOSPHAMIDE

US Patent Number : 9662342

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 210735

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2035-06-26

blank

05

arrow
euroPLX 86 Munich
Not Confirmed
arrow
euroPLX 86 Munich
Not Confirmed

CYCLOPHOSPHAMIDE

US Patent Number : 9662342

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 210735

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2035-06-26

blank

06

arrow
euroPLX 86 Munich
Not Confirmed
arrow
euroPLX 86 Munich
Not Confirmed

CYCLOPHOSPHAMIDE

US Patent Number : 9662342

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 210735

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2035-06-26

blank

07

arrow
euroPLX 86 Munich
Not Confirmed
arrow
euroPLX 86 Munich
Not Confirmed

CYCLOPHOSPHAMIDE

US Patent Number : 10849916

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 210852

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2035-07-13

blank

08

arrow
euroPLX 86 Munich
Not Confirmed
arrow
euroPLX 86 Munich
Not Confirmed

CYCLOPHOSPHAMIDE

US Patent Number : 10849916

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 210852

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2035-07-13

blank

09

arrow
euroPLX 86 Munich
Not Confirmed
arrow
euroPLX 86 Munich
Not Confirmed

CYCLOPHOSPHAMIDE

US Patent Number : 11382923

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 210852

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2035-12-01

blank

10

arrow
euroPLX 86 Munich
Not Confirmed
arrow
euroPLX 86 Munich
Not Confirmed

CYCLOPHOSPHAMIDE

US Patent Number : 11382923

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 210852

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2035-12-01

blank